Factbox: Billion-dollar lawsuits accuse drugmakers, distributors of fueling U.S. opioid crisis
(Reuters) – On Monday, two Ohio counties reached a last-minute settlement with four companies they accused of fueling the nationwide…
by October Gallery
(Reuters) – On Monday, two Ohio counties reached a last-minute settlement with four companies they accused of fueling the nationwide…
CLEVELAND (Reuters) – Four large drug companies reached a last-minute $260 million legal settlement over their role in the U.S.…
LONDON (Reuters) – The world’s first Ebola vaccine was recommended for approval by European drugs regulators on Friday in a…
(Reuters) – Johnson & Johnson said on Friday it is recalling around 33,000 bottles of baby powder in the United…
(Reuters) – Johnson & Johnson said on Friday its investigation into asbestos contamination of its baby powder could take 30…
NEW YORK (Reuters) – Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States…
(Reuters) – The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc’s treatment for a second rare blood…
CLEVELAND (Reuters) – A landmark trial over the U.S. opioid epidemic is on track to begin on Monday after drug…
(Reuters) – Five drugmakers and distributors are offering $22 billion in cash as well as drugs and services they value…
FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference hold by its CEO, Kare Schultz,…
(Reuters) – Three drug distributors are in talks with state and local governments to settle thousands of opioid lawsuits for…
FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock…
FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the…
LONDON (Reuters) – Scientists who resurrected a 50,000-year-old gene sequence have analyzed it to figure out how the world’s deadliest…
NEW YORK (Reuters) – A CVS Health Corp (CVS.N) health plan that uses an outside drug pricing group to help…
(Reuters) – U.S. health officials on Thursday reported 18 deaths due to a mysterious lung illness linked to e-cigarettes and…
FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield, England, May 19, 2014. REUTERS/Phil Noble (Reuters) –…
NEW YORK (Reuters) – The United States has kept its World Health Organization designation as a country that has eliminated…
(Reuters) – Michigan and Pennsylvania state health officials confirmed one death each from a mysterious lung illness linked to e-cigarettes,…
(Reuters) – A New York court on Thursday temporarily halted a state ban on the sale of flavored e-cigarettes, giving…
(Reuters) – About 40% of patients who received a combination of Bristol-Myers Squibb Co’s immuno-oncology drugs Opdivo and Yervoy as…
(Reuters) – An experimental Amgen Inc drug that targets a specific genetic mutation shrank tumors in just one of 12…
BARCELONA (Reuters) – GlaxoSmithKline and AstraZeneca both reported trial results that will likely make their competing drugs available to a…
(Reuters) – People should stop using e-cigarettes, especially those with marijuana ingredient tetrahydrocannabinol (THC), U.S. public health officials recommended on…
CHICAGO (Reuters) – The U.S. investigation into hundreds of cases of life-threatening lung illnesses related to vaping has turned up…
GOMA, Democratic Republic of Congo (Reuters) – Health authorities in Democratic Republic of Congo said on Saturday that they plan…
(Reuters Health) – Health workers who use hand sanitizer between patients may be more likely to spread flu germs than…
An electronic “nose” that detects chemicals in the breath of lung cancer patients may help distinguish between those who will…
FILE PHOTO: U.S. President Donald Trump walks to address the media before boarding Marine One for a trip to New…
FILE PHOTO: U.S. President Donald Trump boards Air Force One as he departs Washington for travel to New Mexico from…
WASHINGTON (Reuters) – U.S. House Speaker Nancy Pelosi, a Democrat, proposed legislation on Thursday to let the federal government negotiate…
FILE PHOTO: Moose, a six-year-old English Bulldog with B-cell lymphoma, receives trial medical treatment at the Tufts Veterinary Medical School…
(Reuters) – For Jessica Lescault there is no question that her 6-year old English bulldog “Moose” deserves cutting-edge biotechnology cancer…
FILE PHOTO: Moose, a six-year-old English Bulldog with B-cell lymphoma, receives trial medical treatment at the Tufts Veterinary Medical School…
(Reuters) – For Jessica Lescault there is no question that her 6-year old English bulldog “Moose” deserves cutting-edge biotechnology cancer…
WASHINGTON (Reuters) – U.S. House Speaker Nancy Pelosi, a Democrat, proposed legislation on Thursday to allow the federal government to…
CHICAGO (Reuters) – U.S. health officials are investigating reports of 380 confirmed and probable cases of serious lung illnesses and…
The logo of Sanofi is seen at the company’s research and production centre in Vitry-sur-Seine, France, August 6, 2019. REUTERS/Charles…
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland…
COPENHAGEN (Reuters) – Novo Nordisk will offer cheaper insulin to U.S. diabetics, the Danish drugmaker said on Friday, in response…
(Reuters) – In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a “Lazarus effect”…
TORONTO (Reuters) – Canada’s main pharmaceutical industry lobby group, along with 16 of its member companies, filed a lawsuit on…
(Reuters) – The U.S. Food and Drug Administration on Friday approved German drugmaker Boehringer Ingelheim’s Ofev capsules for a rare…
(Reuters Health) – Even overweight and obese people who take certain psychiatric drugs associated with weight gain may be able…
A screen displays the logo fro Cigna Corp. on the floor at the New York Stock Exchange (NYSE) in New…
ZURICH (Reuters) – Swiss drugmakers Novartis and Lonza separately deepened their push into so-called biosimilars, betting cheaper copies of name-brand…
(Reuters) – A U.S. judge on Tuesday rejected efforts by major drugmakers, pharmacies and distributors to dismiss claims that they…
(Reuters) – Novartis AG’s gene therapy for blindness, Luxturna, is recommended for use on England’s public health service, the country’s…
NEW YORK (Reuters Health) – Women with a high risk of developing breast cancer can lower that risk by taking…
(Reuters) – The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of…
ZURICH (Reuters) – Swiss drugmaker Novartis on Friday stepped up its challenge to Roche’s multiple sclerosis franchise, highlighting study results…
KAMPALA (Reuters) – A nine-year-old girl has died of Ebola in the East African nation of Uganda, a hospital official…
GOMA, Democratic Republic of Congo (Reuters) – The death toll from Democratic Republic of Congo’s year-long Ebola outbreak has climbed…
(Reuters) – Retrophin Inc said on Thursday it was discontinuing the late-stage study for its rare neurological disorder treatment after…
(Reuters) – The U.S. health regulator on Thursday categorized the recall of Edwards Lifesciences Corp’s Sapien 3 Ultra delivery system…
LONDON, Aug 23 – Eradicating malaria is biologically feasible and a lofty aim, the World Health Organization said on Friday,…
(Reuters) – GlaxoSmithKline said an experimental multiple myeloma treatment has shown a meaningful response in patients that have run out…
GOMA, Congo (Reuters) – Congolese authorities and health workers vaccinated more than 200,000 people against Ebola in August, the government…
(Reuters) – The U.S. Centers for Disease Control and Prevention said on Friday it had identified 193 potential cases of…
(Reuters) – Five pharmaceutical companies said on Friday they have filed a complaint in a Canadian court challenging the constitutionality…